ASPEYA Trademark
Trademark Overview
On Monday, September 23, 2024, a trademark application was filed for ASPEYA with the United States Patent and Trademark Office. The USPTO has given the ASPEYA trademark a serial number of 98764745. The federal status of this trademark filing is REGISTERED as of Tuesday, January 6, 2026. This trademark is owned by Vectura Fertin Pharma Switzerland S.A.. The ASPEYA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations,anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyr...
Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty
Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals
Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems
General Information
| Serial Number | 98764745 |
| Word Mark | ASPEYA |
| Filing Date | Monday, September 23, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 6, 2026 |
| Registration Number | 8091361 |
| Registration Date | Tuesday, January 6, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 18, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations,anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nutraceuticals for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions; pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum for use as an aid to stop smoking |
| Goods and Services | Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty |
| Goods and Services | Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals |
| Goods and Services | Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 23, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ASPEYA SWITZERLAND SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | LAUSANNE 1007
CH |
| Party Name | ASPEYA SWITZERLAND SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | LAUSANNE 1007
CH |
| Party Name | ASPEYA SWITZERLAND SA |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | LAUSANNE 1007
CH |
| Party Name | Vectura Fertin Pharma Switzerland S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Lausanne 1007
CH |
Trademark Events
| Event Date | Event Description |
| Monday, September 23, 2024 | NEW APPLICATION ENTERED |
| Wednesday, December 4, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, December 4, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Friday, March 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 29, 2025 | ASSIGNED TO EXAMINER |
| Saturday, March 29, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, March 29, 2025 | NON-FINAL ACTION E-MAILED |
| Saturday, March 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 11, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, June 27, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 27, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 27, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 29, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 10, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, November 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 6, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 6, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
